These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 11524939

  • 21. The Das-1 immunostain is useful for discriminating metastatic colon adenocarcinoma from cholangiocarcinoma and hepatocellular carcinoma.
    Zimmerman RL, Das KM, Fogt F, Burke M, Murakata LA.
    Oncol Rep; 2002; 9(6):1369-72. PubMed ID: 12375050
    [Abstract] [Full Text] [Related]

  • 22. [Cholangiocellular carcinoma associated with liver cirrhosis].
    Suzuki Y, Aoyagi Y, Naitoh A, Isokawa O.
    Ryoikibetsu Shokogun Shirizu; 1995; (7):357-9. PubMed ID: 8749494
    [No Abstract] [Full Text] [Related]

  • 23. High mobility group A1 is expressed in metastatic adenocarcinoma to the liver and intrahepatic cholangiocarcinoma, but not in hepatocellular carcinoma: its potential use in the diagnosis of liver neoplasms.
    Abe N, Watanabe T, Izumisato Y, Suzuki Y, Masaki T, Mori T, Sugiyama M, Fusco A, Atomi Y.
    J Gastroenterol; 2003; 38(12):1144-9. PubMed ID: 14714251
    [Abstract] [Full Text] [Related]

  • 24. Accuracy of the preoperative determination of tumor markers in the differentiation of liver mass lesions in surgical patients.
    Torzilli G, Makuuchi M, Ferrero A, Takayama T, Hui AM, Abe H, Inoue K, Nakahara K.
    Hepatogastroenterology; 2002; 49(45):740-5. PubMed ID: 12063982
    [Abstract] [Full Text] [Related]

  • 25. Recent advances in the management of cholangiocarcinomas.
    Vauthey JN, Blumgart LH.
    Semin Liver Dis; 1994 May; 14(2):109-14. PubMed ID: 8047893
    [No Abstract] [Full Text] [Related]

  • 26. [Cholangiocellular carcinoma (intrahepatic bile duct carcinoma)].
    Shimazu M.
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():396-400. PubMed ID: 11761979
    [No Abstract] [Full Text] [Related]

  • 27. Hepatocellular carcinoma and cholangiocarcinoma: an update.
    Yazici C, Niemeyer DJ, Iannitti DA, Russo MW.
    Expert Rev Gastroenterol Hepatol; 2014 Jan; 8(1):63-82. PubMed ID: 24245910
    [Abstract] [Full Text] [Related]

  • 28. MR imaging of the liver. Primary malignant neoplasms in the adult.
    Buetow PC, Midkiff RB.
    Magn Reson Imaging Clin N Am; 1997 May; 5(2):289-318. PubMed ID: 9113676
    [Abstract] [Full Text] [Related]

  • 29. [Combined hepatocellular-cholangiocarcinoma].
    Jeen YM, Jin SY.
    Korean J Hepatol; 2007 Dec; 13(4):571-5. PubMed ID: 18159156
    [No Abstract] [Full Text] [Related]

  • 30. [Diagnosis and treatment of cholangiocarcinoma].
    Korean J Hepatol; 2005 Dec; 11 Suppl 1():48-58. PubMed ID: 23570223
    [No Abstract] [Full Text] [Related]

  • 31. Hepatobiliary Cancers: Progress in Diagnosis, Pathogenesis, and Treatment.
    Pant K, Gradilone SA.
    Technol Cancer Res Treat; 2022 Dec; 21():15330338221097203. PubMed ID: 35546130
    [Abstract] [Full Text] [Related]

  • 32. Biomarkers of intrahepatic cholangiocarcinoma: diagnosis and response to therapy.
    Brown ZJ, Hewitt DB, Pawlik TM.
    Front Biosci (Landmark Ed); 2022 Mar 05; 27(3):85. PubMed ID: 35345317
    [Abstract] [Full Text] [Related]

  • 33. [Carcinoma with predominant lymphoid stroma in hepatobiliary system--report of 2 cases].
    Min HS, Shin E, Jang JJ.
    Korean J Hepatol; 2007 Jun 05; 13(2):222-7. PubMed ID: 17585195
    [Abstract] [Full Text] [Related]

  • 34. Intrahepatic cholangiocarcinoma: a malignancy of increasing importance.
    Hammill CW, Wong LL.
    J Am Coll Surg; 2008 Oct 05; 207(4):594-603. PubMed ID: 18926465
    [No Abstract] [Full Text] [Related]

  • 35. ACG clinical guideline: the diagnosis and management of focal liver lesions.
    Marrero JA, Ahn J, Rajender Reddy K, Americal College of Gastroenterology.
    Am J Gastroenterol; 2014 Sep 05; 109(9):1328-47; quiz 1348. PubMed ID: 25135008
    [Abstract] [Full Text] [Related]

  • 36. The utility of hepatocyte paraffin 1 antibody in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma and metastatic carcinoma.
    Shiran MS, Isa MR, Sherina MS, Rampal L, Hairuszah I, Sabariah AR.
    Malays J Pathol; 2006 Dec 05; 28(2):87-92. PubMed ID: 18376797
    [Abstract] [Full Text] [Related]

  • 37. Review article: the modern diagnosis and therapy of cholangiocarcinoma.
    Malhi H, Gores GJ.
    Aliment Pharmacol Ther; 2006 May 01; 23(9):1287-96. PubMed ID: 16629933
    [Abstract] [Full Text] [Related]

  • 38. Hepatobiliary cancers, version 2.2014.
    Benson AB, D'Angelica MI, Abrams TA, Are C, Bloomston PM, Chang DT, Clary BM, Covey AM, Ensminger WD, Iyer R, Kelley RK, Linehan D, Malafa MP, Meranze SG, Park JO, Pawlik T, Posey JA, Scaife C, Schefter T, Sigurdson ER, Tian GG, Vauthey JN, Venook AP, Yen Y, Zhu AX, Hoffmann KG, McMillian NR, Sundar H.
    J Natl Compr Canc Netw; 2014 Aug 01; 12(8):1152-82. PubMed ID: 25099447
    [Abstract] [Full Text] [Related]

  • 39. What is the current state-of-the-art imaging for detection and staging of cholangiocarcinoma?
    Slattery JM, Sahani DV.
    Oncologist; 2006 Sep 01; 11(8):913-22. PubMed ID: 16951395
    [Abstract] [Full Text] [Related]

  • 40. Intrahepatic cholangiocarcinoma diagnosed preoperatively as hepatocellular carcinoma.
    Yamamoto M, Ariizumi S, Otsubo T, Katsuragawa H, Katagiri S, Nakano M, Takasaki K.
    J Surg Oncol; 2004 Aug 01; 87(2):80-3; discussion 83-4. PubMed ID: 15282700
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.